Is Now a Great Time to Buy Innovative Industrial Properties Inc. (IIPR)?

NYSE: IIPR | Innovative Industrial Properties, Inc.  News, Ratings, and Charts

IIPR – Just as we thought the selling was over for Innovative Industrial Properties Inc. (IIPR), things got worse.

Just as we thought the selling was over for Innovative Industrial Properties Inc. (IIPR), things got worse. Over the past 90 days, the stock tumbled over 30% and investors are wondering if now is the time to pick up some shares at these lower prices.

If you look at the year to date performance, IIPR’s stock is still up an impressive 80%, which has beat the market by a long shot. It was almost as if the market put IIPR in a category of its own, despite the weakness in the cannabis sector overall.  

That was until the company issued 1.25 million shares right around the time when the stock was trading at an all-time high.  As a result, the share price started to fall immediately in the days following the announcement. 

Now although the company has raised over 100 million dollars and put that capital to work almost immediately, investors were concerned that further dilution is on the way. 

However, we still think the best is yet to come for IIPR…

2019 has been a transitional year for IIPR and they have expanded their portfolio from a mere 11 properties to an astonishing 31 properties, with their most recent acquisition of Cresco Labs’ property in Illinois. As IIPR grows and expands they continue to diversify their revenue streams with each property. 

One of the great things about IIPR is that the company pays a hefty dividend. At current levels, the company pays more than 4% which is more impressive than some consumer staples or even major utility companies in the United States. The more IIRP drops, the more the dividend increases, which should attract swarms of income investors looking for a high yielding stock with massive growth potential. 

Another thing we like about the company is the fact that they are laser-focused on the medical marijuana market, only signing quality tenants on long-term, triple-net lease agreements. 

Something investors also need to pay attention to is the potential for the SAFE banking act to pass, that currently sits with the Senate right now. This will allow cannabis companies to obtain traditional financing and insurance, something that might come in handy next time IIPR looks to raise additional capital if cannabis is not federally legal by then.

 

We see the recent drop in IIPR as a buying opportunity.  Their focus on medical marijuana is beneficial, as it is more predictable and should generate more stable streams of income for the tenants that are occupying IIPR’s properties. That combined with the hefty dividend at current levels and the possibility of the SAFE banking act passing, makes IIPR an attractive cannabis stock to watch for the rest of 2019 and beyond. 

 


IIPR shares were trading at $70.88 per share on Thursday morning, down $0.66 (-0.92%). Year-to-date, IIPR has gained 59.03%, versus a 21.83% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
IIPRGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
ACBGet RatingGet RatingGet Rating
CRONGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating
CTSTGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More Innovative Industrial Properties, Inc. (IIPR) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All IIPR News